Ovation ScienceOVATF Receivables Turnover is 2.44 as of Mar. 2026. The stock has 4 warning signs investors should review. Among 943 Drug Manufacturers companies, Ovation Science ranks better than 92.05% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Ovation Science's Revenue for the
three
months ended in Mar. 2026 was $0.01 Mil. Ovation Science's average Accounts Receivable for the
three
months ended in Mar. 2026 was $0.00 Mil.
Hence, Ovation Science's Receivables Turnover for the
three
months ended in Mar. 2026 was 2.44.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Ovation Science Receivables Turnover Related Terms
Ovation Science Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Ovation Science's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OVATF vs ZTS, UTHR: Receivables Turnover Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Ovation Science's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ovation Science Receivables Turnover vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ovation Science's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Ovation Science's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ovation Science (OVATF) has a Receivables Turnover of 2.44 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ovation Science and its competitors. According to the industry distribution chart, Ovation Science ranks #75 out of 943 companies in the Drug Manufacturers industry, placing it in the top 8%.
Is Ovation Science's Receivables Turnover too high?
Ovation Science's current Receivables Turnover is 2.44. The Drug Manufacturers industry median Receivables Turnover is 5.07. Ovation Science's value of 2.44 is 51.9% below this industry median. Based on the distribution chart, Ovation Science ranks #75 out of 943 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers.
How does Ovation Science's Receivables Turnover compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Ovation Science ranks #75 out of 943 companies for Receivables Turnover. This places Ovation Science in the top 8% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.07. Ovation Science's value of 2.44 is 51.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Drug Manufacturers company?
The median Receivables Turnover among Drug Manufacturers companies is 5.07, based on 943 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ovation Science's current Receivables Turnover of 2.44 is 51.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Ovation Science and its competitors. For the Drug Manufacturers industry, the median Receivables Turnover is 5.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ovation Science's current Receivables Turnover is 2.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ovation Science stock overvalued right now?
Ovation Science (OVATF) has a current Receivables Turnover of 2.44. The stock's GF Value™ is $0.05, compared to a current price of $0.04 — trading 30% below its estimated fair value. The current Receivables Turnover is 2.44 and 51.9% below the Drug Manufacturers industry median of 5.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Ovation Science (OVATF), the current Receivables Turnover is 2.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Ovation Science Inc. is a Canada-based company mainly engaged in the business of providing topical and transdermal cannabis products under the Ovation brand label, utilizing patented Invisicare delivery technology. The Company operates in one reportable operating segment, the sub-licensing and sales of cannabis products that utilize Invisicare, a patented polymer-based technology for topical and transdermal skin care products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OVATF has been successfully added to your 